Please Wait

Applying Filters...

Glucagon
CEP/COS
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Glucagon

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 7 USDMF, 1 CEP/COS, 3 JDMF, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

FINISHED DOSAGE FORMULATIONS

20 FDF Dossiers, 9 FDA Orange Book, 8 Europe, 1 Canada, 1 South Africa, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 4 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 19 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 8 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 13 Direct Compression, 10 Granulation, 9 Thickeners and Stabilizers, 9 Lubricants & Glidants, 9 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 4 Controlled & Modified Release, 3 Coating Systems & Additives, 2 Taste Masking, 2 Parenteral, 2 Chewable & Orodispersible Aids, 1 Film Formers & Plasticizers, 1 Rheology Modifiers, 1 Emulsifying Agents